1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Genpharmasec Ltd.

Genpharmasec Ltd.

GENPHARMA.BO
Genpharmasec Ltd.IN flagBombay Stock Exchange
1.06
INR
-0.03
- -
586.94MMarket Cap
Genpharmasec Ltd.
GENPHARMA.BO
(Bombay Stock Exchange)

Recent

price

1.06

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
1.65
0.45
0.88
- -
0.03
- -
0.88
0.15
0.01
0.46
0.46
0.58
0.55
0.59
0.64
- -
2.37
Revenue per Share
-0.22
-0.24
0.01
0.04
0.04
0.18
0.03
0.09
0.01
0.03
0.03
- -
0.02
- -
0.03
- -
0.01
Basic EPS, GAAP
-0.03
-0.18
-0.04
0.03
0.05
0.19
-0.09
0.27
-0.18
0.04
-0.05
-0.05
-0.07
-0.06
-0.05
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.8
-1.95
-2.58
-1.88
-1.71
-1.88
-1.7
-1.59
0.57
0.6
0.64
0.49
0.5
0.99
0.98
- -
0.94
Book Value per Share
-1.8
-1.95
-2.58
-1.88
-1.71
-1.7
-1.67
-1.59
0.6
0.53
0.46
0.33
0.33
1.26
1.23
- -
0.8
Tangible Book Value per Share
5
6
4
6
6
5
5
5
361
361
452
461
461
512
529
- -
591
Basic Weighted Avg Shares
9
2
4
- -
- -
- -
5
1
4
165
208
266
253
304
337
1,399
1,399
Sales/Revenue/Turnover
-2.26
-53.7
1.25
- -
-1,815.7
- -
2.68
-31.68
-23.31
3.93
3.24
-4.68
0.31
1.42
-1.23
-0.68
-0.68
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
22
22
Depreciation Expense
-1
-1
- -
- -
- -
1
- -
- -
2
10
13
-2
11
-2
16
16
8
Net Income, GAAP
- -
- -
- -
1.77
0.48
- -
- -
25.81
19.68
16.26
16.7
- -
- -
167.56
29.34
42.3
42.3
Effective Tax Rate (%)
-13.11
-53.7
1.36
- -
129.53
- -
3.21
58.5
61.56
6.12
6.05
-0.79
4.45
-0.56
4.7
1.15
0.6
Profit Margin (%)
- -
- -
- -
- -
- -
1
1
1
77
102
196
153
169
383
175
335
335
Working Capital
10
11
11
11
11
10
10
10
- -
- -
- -
- -
25
39
48
253
253
LT Debt
-10
-11
-11
-10
-10
-9
-9
-9
216
190
207
154
153
645
653
656
656
Total Equity
4.88
- -
- -
-10.78
-859.98
- -
- -
-13.93
-0.65
2.66
2.82
- -
- -
-0.67
-0.42
-0.63
-0.63
Return on Invested Capital (%)
28.33
- -
- -
6.08
61.64
- -
- -
38.26
2.22
4.75
4.96
- -
- -
-0.99
3.42
4.57
2.48
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.75
4.96
-0.81
4.9
-0.46
3.09
2.99
1.55
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
23
- -
96
LT Borrowings
74
- -
240
LT Finance Leases
14
- -
14
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
554
- -
554
Market Capitalization
1,094
754
461

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
561
- -
805
Cash, Cash Equivalents & STI
53
- -
110
Accounts Receivable, Net
245
- -
293
Inventories
196
- -
139
Total Current Liabilities
496
- -
470
Payables & Accruals
- -
- -
- -
ST Debt
23
- -
96
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-231.63%
59.32%
0.56%
Free Cash Flow
-487.2%
117.09%
556.38%
Net Income, GAAP
-103.26%
-380.91%
1.09%
Sales/Revenue/Turnover
- -
73.82%
314.98%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
79
64
102
304
2025
52
60
85
140
337
2026
120
326
398
554
1,399

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.01
0.01
0.01
-0.01
0.03
2026
0.02
-0.02
-0.01
0.02
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Asian Paints Limited (ASIANPAINT.BO)
Krakchemia S.A. (KCH.WA)
Polyplex (Thailand) Public Company Limited (PTL.BK)
Asian Petroproducts & Exports Ltd. (ASINPET.BO)
Jiangsu Baichuan High-Tech New Materials Co., Ltd (002455.SZ)
Hodogaya Chemical Co., Ltd. (4112.T)
Business
Genpharmasec Limited operates within the healthcare domain, focusing on the distribution of advanced diagnostic equipment and offering laboratory testing services, alongside its involvement in equity share trading. The company's operations are structured across key segments including Diagnostic Pharma Equipment, Trading in Securities, and Laboratory Testing. Notably, it holds distribution rights for i-STAT Analyzers and associated cartridges from Abbott Point of Care, USA, catering to critical care units in hospitals across India, providing rapid blood analysis. Further expanding its footprint in healthcare, Genpharmasec is strategically acquiring a stake in Derren Healthcare Private Limited to venture into injectable manufacturing and has established Clinigenome India Private Limited as a wholly-owned subsidiary to develop a network of clinical laboratories throughout major Indian cities. The company was initially incorporated on November 16, 1992, and maintains its headquarters in Mumbai, India.